RepliCel Life Sciences Inc.

OTCPK:REPC.F Stock Report

Market Cap: US$2.8m

RepliCel Life Sciences Management

Management criteria checks 3/4

RepliCel Life Sciences' CEO is Andrew Schutte, appointed in Nov 2022, has a tenure of 1.5 years. directly owns 26.77% of the company’s shares, worth $745.40K. The average tenure of the management team and the board of directors is 1.5 years and 5.4 years respectively.

Key information

Andrew Schutte

Chief executive officer

CA$8.9k

Total compensation

CEO salary percentagen/a
CEO tenure1.5yrs
CEO ownership26.8%
Management average tenure1.5yrs
Board average tenure5.4yrs

Recent management updates

Recent updates

CEO

Andrew Schutte (33 yo)

1.5yrs

Tenure

CA$8,917

Compensation

Mr. Andrew Schutte serves as President, Chief Executive Officer & Director of RepliCel Life Sciences Inc. since November 28, 2022. He served as an Independent Director of RepliCel Life Sciences Inc. since...

Leadership Team

NamePositionTenureCompensationOwnership
Andrew Schutte
President1.5yrsCA$8.92k26.77%
CA$ 745.4k
Kevin McElwee
Co-Founder & Chief Scientific Officer12.8yrsCA$30.00k2.04%
CA$ 56.9k
Ben Austring
Chief Legal Officer1.5yrsCA$14.50k0.49%
CA$ 13.7k
Rolf Hoffmann
Chief Medical Officer & Member of Clinical Advisory Board13.4yrsno data0.75%
CA$ 21.0k
David Kwok
Chief Financial Officerless than a yearno datano data

1.5yrs

Average Tenure

53yo

Average Age

Experienced Management: REPC.F's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Andrew Schutte
President5.4yrsCA$8.92k26.77%
CA$ 745.4k
Rolf Hoffmann
Chief Medical Officer & Member of Clinical Advisory Boardno datano data0.75%
CA$ 21.0k
David Hall
Independent Chairman of the Board13.4yrsCA$17.75k1.35%
CA$ 37.5k
Jean Krutmann
Member of Clinical Advisory Boardno datano datano data
Ross Davidson
Chairman of Clinical Advisory Board10.6yrsno datano data
Peter Lewis
Independent Director13yrsCA$14.45k0.96%
CA$ 26.9k
R. Buckler
Director8.3yrsCA$240.85k0.010%
CA$ 291.5
Gary Boddington
Independent Director2.9yrsCA$16.25k0.48%
CA$ 13.5k
Jamie MacKay
Directorless than a yearno data15.44%
CA$ 429.8k
Tsukasa Kumai
Member of Clinical Advisory Boardno datano datano data
Akimichi Morita
Member of Clinical Advisory Board3yrsno datano data
Kunihiko Suzuki
Senior Strategic Advisor to Directors2.6yrsno datano data

5.4yrs

Average Tenure

61yo

Average Age

Experienced Board: REPC.F's board of directors are considered experienced (5.4 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.